Earnings History Data for Black Diamond Therapeutics (BDTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Black Diamond Therapeutics
Black Diamond Therapeutics Inc. is an oncology medicine company. It engages in discovery and development of small molecule, tumor-agnostic therapies. The company's lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor and tyrosine-protein kinase. Black Diamond Therapeutics Inc. is based in Cambridge, Massachusetts.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
06-08-2024 | PM | BDTX | Black Diamond Therapeutics | 324.00 | -0.36 | -0.39 | 0.00 | Black Diamond Therapeutics GAAP EPS of -$0.36 beats by $0.03 [8/6/2024 7:43 AM] |
5.00 | -0.30 (-5.66%) |
0.0 | 0.0 (0.00%) |
1.62 - 7.66 | 593,020 | 430,000 | 0 | ||
09-05-2024 | PM | BDTX | Black Diamond Therapeutics | 378.00 | -0.35 | -0.44 | 0.00 | Black Diamond Therapeutics GAAP EPS of -$0.35 beats by $0.08 [5/9/2024 7:54 AM] |
6.75 | -0.19 (-2.77%) |
0.0 | 0.0 (0.00%) |
1.57 - 7.66 | 573,013 | 930,000 | 0 | ||
12-03-2024 | PM | BDTX | Black Diamond Therapeutics | 210.00 | -0.34 | -0.47 | 0.00 | 3.77 | -0.23 (-5.72%) |
0.0 | 0.0 (0.00%) |
1.30 - 6.85 | 308,184 | 500,000 | 0 | |||
|
||||||||||||||||||
06-11-2023 | PM | BDTX | Black Diamond Therapeutics | 93.00 | -0.45 | -0.49 | 0.00 | Black Diamond Therapeutics GAAP EPS of -$0.45 beats by $0.04 [11/6/2023 11:48 AM] |
1.93 | 0.03 (1.45%) |
1.97 | 0.07 (3.68%) |
1.22 - 6.85 | 382,724 | 390,000 | 1,713 | ||
11-08-2023 | PM | BDTX | Black Diamond Therapeutics | 120.00 | -0.52 | -0.54 | 0.00 | Black Diamond Therapeutics GAAP EPS of -$0.52 beats by $0.02 [8/11/2023 7:43 AM] |
3.34 | -0.07 (-2.05%) |
3.36 | -0.05 (-1.47%) |
1.18 - 6.85 | 242,486 | 450,000 | 4,047 | ||
09-05-2023 | PM | BDTX | Black Diamond Therapeutics | 72.00 | -0.57 | -0.61 | 0.00 | Black Diamond Therapeutics GAAP EPS of -$0.57 beats by $0.04 [5/9/2023 8:46 AM] |
1.82 | -0.10 (-5.21%) |
1.95 | 0.03 (1.56%) |
1.18 - 4.08 | 46,047 | 60,000 | 176 | ||
09-03-2023 | PM | BDTX | Black Diamond Therapeutics | 62.00 | -0.59 | -0.63 | 0.00 | Black Diamond Therapeutics GAAP EPS of -$0.59 beats by $0.04 [3/9/2023 9:00 AM] |
1.45 | -0.23 (-13.50%) |
1.74 | 0.06 (3.57%) |
1.18 - 4.08 | 611,376 | 60,000 | 748 | ||
08-11-2022 | PM | BDTX | Black Diamond Therapeutics | 80.00 | -0.60 | -0.64 | 0.00 | Black Diamond Therapeutics GAAP EPS of -$0.60 beats by $0.04 [11/8/2022 9:13 AM] |
2.29 | 0.08 (3.62%) |
2.16 | -0.05 (-2.26%) |
1.18 - 8.71 | 100,150 | 400,000 | 1,160 | ||
09-08-2022 | PM | BDTX | Black Diamond Therapeutics | 135.00 | -0.63 | -0.68 | 0.00 | Black Diamond Therapeutics GAAP EPS of -$0.63 beats by $0.07 [8/9/2022 8:33 AM] |
3.80 | 0.04 (1.06%) |
3.73 | -0.03 (-0.80%) |
1.46 - 10.47 | 248,461 | 150,000 | 627 | ||
11-05-2022 | AH | 5:00 PM ET (May 11) |
BDTX | Black Diamond Therapeutics | 70.00 | -0.70 | -0.75 | 0.00 | Black Diamond Therapeutics GAAP EPS of -$0.70 [5/11/2022 4:52 PM] |
1.83 | -0.04 (-2.14%) |
0.0 | 0.0 (0.00%) |
1.78 - 28.36 | 133,114 | 280,000 | 0 | |
17-03-2022 | AH | BDTX | Black Diamond Therapeutics | 100.00 | -0.71 | -1.01 | 0.00 | Black Diamond Therapeutics GAAP EPS of -$0.71 beats by $0.30 [3/17/2022 5:33 PM] |
3.14 | 0.12 (3.97%) |
2.91 | -0.11 (-3.64%) |
2.60 - 29.02 | 228,850 | 609,659 | 2,914 | ||
08-11-2021 | PM | BDTX | Black Diamond Therapeutics | 299.00 | -0.97 | -0.98 | 0.00 | Black Diamond Therapeutics EPS beats by $0.01 [11/8/2021 7:53 AM] |
8.20 | 0.16 (1.99%) |
8.30 | 0.26 (3.23%) |
7.55 - 37.76 | 136,576 | 170,000 | 3,251 | ||
12-08-2021 | PM | BDTX | Black Diamond Therapeutics, Inc. | 355.00 | -0.95 | -0.87 | 0.00 | Black Diamond Therapeutics EPS misses by $0.08 [8/12/2021 8:39 AM] |
9.70 | 0.25 (2.65%) |
9.70 | 0.0 (0.00%) |
8.75 - 37.76 | 242,249 | 280,000 | 5,046 | ||
07-05-2021 | PM | BDTX | Black Diamond Therapeutics, Inc. | 894.00 | -0.84 | -0.67 | 0.00 | Black Diamond Therapeutics EPS misses by $0.16 [5/7/2021 7:56 AM] |
25.50 | -0.05 (-0.20%) |
25.50 | 0.0 (0.00%) |
21.04 - 46.25 | 272,434 | 260,000 | 4,259 | ||
25-03-2021 | PM | BDTX | Black Diamond Therapeutics, Inc. | 858.00 | -0.63 | -0.63 | 0.00 | Black Diamond Therapeutics EPS in-line [3/25/2021 7:59 AM] |
22.93 | 0.51 (2.27%) |
24.00 | 1.58 (7.05%) |
20.75 - 46.25 | 737,237 | 410,000 | 541 | ||
10-11-2020 | PM | BDTX | Black Diamond Therapeutics, Inc. | 1,190 | -0.50 | -0.53 | 0.00 | Black Diamond Therapeutics EPS beats by $0.02 [11/10/2020 8:02 AM] |
34.03 | 1.97 (6.14%) |
32.06 | 0.0 (0.00%) |
17.63 - 46.25 | 423,119 | 179,017 | 497 | ||
|
||||||||||||||||||
11-08-2020 | PM | 7:45 AM ET (Aug 11) |
BDTX | Black Diamond Therapeutics, Inc. | 1,090 | -0.41 | -0.43 | 0.00 | Black Diamond Therapeutics EPS beats by $0.03 [8/11/2020 7:49 AM] |
30.50 | -2.06 (-6.31%) |
32.56 | 0.0 (0.00%) |
17.63 - 46.25 | 47,637 | 131,144 | 533 | |
|